- Home
- TCRX vs FDSB Comparison
TCRX vs FDSB Comparison
Compare TCRX & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- FDSB
- Stock Information
- Founded
- TCRX 2018
- FDSB 1926
- Country
- TCRX United States
- FDSB United States
- Employees
- TCRX N/A
- FDSB N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- FDSB
- Sector
- TCRX Health Care
- FDSB
- Exchange
- TCRX Nasdaq
- FDSB NYSE
- Market Cap
- TCRX 82.1M
- FDSB 69.2M
- IPO Year
- TCRX 2021
- FDSB N/A
- Fundamental
- Price
- TCRX $1.93
- FDSB $13.18
- Analyst Decision
- TCRX Strong Buy
- FDSB
- Analyst Count
- TCRX 6
- FDSB 0
- Target Price
- TCRX $9.50
- FDSB N/A
- AVG Volume (30 Days)
- TCRX 572.1K
- FDSB 23.0K
- Earning Date
- TCRX 08-11-2025
- FDSB 08-15-2025
- Dividend Yield
- TCRX N/A
- FDSB N/A
- EPS Growth
- TCRX N/A
- FDSB N/A
- EPS
- TCRX N/A
- FDSB 0.02
- Revenue
- TCRX $4,421,000.00
- FDSB $12,612,000.00
- Revenue This Year
- TCRX $159.20
- FDSB N/A
- Revenue Next Year
- TCRX N/A
- FDSB N/A
- P/E Ratio
- TCRX N/A
- FDSB $547.95
- Revenue Growth
- TCRX N/A
- FDSB 40.41
- 52 Week Low
- TCRX $1.02
- FDSB $9.85
- 52 Week High
- TCRX $7.44
- FDSB $14.50
- Technical
- Relative Strength Index (RSI)
- TCRX 63.03
- FDSB N/A
- Support Level
- TCRX $1.75
- FDSB N/A
- Resistance Level
- TCRX $1.96
- FDSB N/A
- Average True Range (ATR)
- TCRX 0.14
- FDSB 0.00
- MACD
- TCRX 0.01
- FDSB 0.00
- Stochastic Oscillator
- TCRX 94.00
- FDSB 0.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.